Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jan 15, 2025; 17(1): 99272
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.99272
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.99272
Table 3 Comparison of immune function indicators between the two groups after treatment (mean ± SD)
Group | CD3+ (%) | CD4+ (%) | CD8+ (%) | CD4+/CD8+ | Treg cell (%) | NK cell (%) |
Observation (n = 58) | 61.28 ± 5.84a | 38.84 ± 3.58a | 21.58 ± 2.08a | 1.81 ± 0.18a | 2.08 ± 0.65a | 21.26 ± 3.28a |
Control (n = 58) | 52.84 ± 5.80a | 33.10 ± 3.48a | 24.63 ± 2.12a | 1.34 ± 0.14a | 3.07 ± 0.72a | 24.95 ± 3.35a |
t | 7.809 | 8.756 | 7.821 | 15.697 | 7.773 | 5.994 |
P value | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
- Citation: Shi XJ, Song Y, Liang XX, Chen T, Hao HY, Han X, Chen YN. Effects of Shenqi Xiangyi granules in advanced gastric cancer chemotherapy. World J Gastrointest Oncol 2025; 17(1): 99272
- URL: https://www.wjgnet.com/1948-5204/full/v17/i1/99272.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i1.99272